Portfolio comparison
University of Pennsylvania Penn vs Genentech Inc
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
University of Pennsylvania Penn
Patents indexed
4
Year range
2012 – 2024
Most recent
2024
biotechpharmaceuticalgene_editingoncologytelecommunications
Top Patents4 enriched
US 8278036· 2012
How Modified RNA Tricks Cells Into Making Proteins Without Triggering Attacks
US 9481728· 2016
How Genetically Modified T-Cells Fight CD19 Cancers
US 9328156· 2016
How Genetically Modified T-Cells Attack Cancer
Activity by Decade
2010s3
2020s1
Company B
Genentech Inc
Patents indexed
13
Year range
1982 – 2017
Most recent
2017
biotechpharmaceuticalgene_editinghealthcareoncology
Top Patents13 enriched
US 4816567· 1989
Making Hybrid Antibodies from Different Animals
US 7527791· 2009
How Engineered Antibodies Target TGF-beta Proteins to Fight Cancer
US 6054297· 2000
How to Redesign Mouse Antibodies for Safe Use in Humans
Activity by Decade
1980s2
2000s8
2010s3
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.